RAYMOND JAMES & ASSOCIATES - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 33 filers reported holding AGILE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$25,000
-30.6%
26,500
-1.3%
0.00%
Q2 2021$36,000
-35.7%
26,8450.0%0.00%
Q1 2021$56,000
-30.9%
26,845
-5.3%
0.00%
Q4 2020$81,000
-5.8%
28,3500.0%0.00%
Q3 2020$86,000
+32.3%
28,350
+20.6%
0.00%
Q2 2020$65,000
+47.7%
23,5000.0%0.00%
Q1 2020$44,000
+2.3%
23,500
+38.2%
0.00%
Q4 2019$43,000
+760.0%
17,000
+36.0%
0.00%
Q3 2018$5,000
-16.7%
12,5000.0%0.00%
Q2 2018$6,000
-97.6%
12,500
-54.2%
0.00%
-100.0%
Q1 2015$253,00027,2790.00%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Perceptive Advisors 31,839,850$42,348,0000.28%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$978,0000.14%
INVESTOR AB 3,510,189$4,669,0000.14%
Tibra Equities Europe Ltd 241,100$321,0000.10%
FIRST MIDWEST BANK TRUST DIVISION 349,158$464,0000.06%
GSA CAPITAL PARTNERS LLP 372,543$495,0000.06%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 110,000$146,0000.04%
Kalos Management, Inc. 19,250$24,0000.01%
Summit Global Investments 110,100$146,0000.01%
Founders Capital Management 10,000$13,0000.01%
View complete list of AGILE THERAPEUTICS INC shareholders